A nanoantibody binds norovirus particles to block intestinal cell infection.
Combining CHIR99021 with valproic acid replaces Paneth cell contact to expand Lgr5+ stem cells while maintaining self-renewal fidelity.
Isolates intestinal stem cells via extraction and intermediary support to resolve the trade-off between symptom control and addressing root cause mechanisms.
Adjusted growth factor concentrations in the culture medium increase passaging success rates for patient-derived esophageal organoids.
A high-throughput method fabricates biomaterial-encapsulated cell masses using photo-crosslinkable hydrogels and automated imaging analysis.
Segmented hydrogel layers resolve manufacturing precision limits by replicating natural epithelial tissue deformations under specific compressive strains.
A patterned cell culture substrate directs stem cell adhesion and differentiation into small intestinal epithelial cells.
A gel substrate with an air-liquid interface enables continuous growth of mammalian intestinal cells for extended periods.
Recombinant adenoviruses exploit defective p53 pathways to selectively replicate in cancer cells while sparing normal tissue.